Specific binding members for NGF
US9315571B2 · kind B2 · utility
1Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 24, 2006 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Dec 24, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.